32018-31-8Relevant articles and documents
NOVEL IMIDE DERIVATIVES AND USE THEREOF AS MEDICINE
-
Paragraph 0121, (2018/05/24)
Provided is a novel low-molecular-weight compound that suppresses production of induction type MMPs, particularly MMP-9, rather than production of hemostatic type MMP-2. The present invention relates to a compound represented by the following formula (I): wherein each symbol is as described in the DESCRIPTION. The compound has a selective MMP-9 production suppressive action, and is useful as a drug for the prophylaxis and/or treatment of autoimmune diseases such as rheumatoid arthritis and the like, inflammatory bowel diseases (ulcerative colitis, Crohn's disease) or osteoarthritis.
Hypoglycemic prodrugs of 4-(2,2-dimethyl-1-oxopropyl)benzoic acid
Aicher, Thomas D.,Bebernitz, Gregory R.,Bell, Philip A.,Brand, Leonard J.,Dain, Jeremy G.,Deems, Rhonda,Fillers, William S.,Foley, James E.,Knorr, Douglas C.,Nadelson, Jeffrey,Otero, Dario A.,Simpson, Ronald,Strohschein, Robert J.,Young, Douglas A.
, p. 153 - 163 (2007/10/03)
SAH 51-641 (1) is a potent hypoglycemic agent, which acts by inhibiting hepatic gluconeogenesis. It is a prodrug of 4-(2,2-dimethyl-1- oxopropyl)benzoic acid (2) and 4-(2,2-dimethyl-1-hydroxypropyl)benzoic acid (3), which sequester coenzyme A (CoA) in the